

Invest with us
Investor portal
Access all forms, offer documents and Target Market Determinations
Existing investor access
Register for access to the web portal
View listed holdings in PIXX or PAXX
Existing adviser access
Invest online
You can invest right now with our simple, secure online application
Invest online
Platform availability and Research ratings
Key documents
| Platinum International Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum International Fund Active ETF (ASX:PIXX) | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) | |
| Fees and Costs |
| Platinum Asia Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum Asia Fund Complex ETF (ASX:PAXX) | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) | |
| Fees and Costs |
| Platinum Japan Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum European Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum International Technology Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum International Brands Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum International Health Sciences Fund | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
| Platinum Global Fund (Long Only) | |
|---|---|
| Product Disclosure Statement (PDS) | |
| Target Market Determination (TMD) - C Class | |
| Target Market Determination (TMD) - P Class | |
| Additional Investment form | |
| Update my details | |
| Switch an investment | |
| Transfer an investment | |
| Withdrawal requests | |
| Authorise someone to access my account (individual representative) | |
| Authorise someone to access my account (corporate representative) | |
| Fees and Costs |
Platinum Trust documents
| Download | |
|---|---|
| May 2026 | |
| April 2026 | |
| March 2026 | |
| February 2026 | |
| January 2026 | |
| December 2025 | |
| November 2025 | |
| October 2025 | |
| September 2025 | |
| August 2025 | |
| July 2025 | |
| June 2025 |
Continuous disclosure
Zenith
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating assigned to Platinum International Fund (27 November 2025), Platinum Asia Fund (13 November 2025), Platinum Japan Fund (13 November 2025), Platinum European Fund (13 November 2025), Platinum International Technology Fund (13 November 2025), Platinum International Brands Fund (13 November 2025), Platinum International Health Sciences Fund (13 November 2025), Platinum Global Fund (Long Only) (13 November 2025), referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.
Lonsec
The ratings issued for Platinum International Fund (January 2026), Platinum Asia Fund (February 2026), Platinum Japan Fund (April 2026), Platinum European Fund (April 2026), Platinum International Technology Fund (April 2026), Platinum International Brands Fund (April 2026), Platinum International Health Sciences Fund (April 2026), Platinum Global Fund (Long Only) (January 2026) are published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. Copyright 2023 Lonsec. All rights reserved.